Company / Operating Income
Korro Bio, Inc. Operating Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$91.9M
FY2025
5-year range
-$91.9M / -$20.7M
FY2021-FY2025
Trend
-8.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has declined for 5 consecutive years, from -$16M in FY2019 to -$92M in FY2025.
Based on SEC 10-K filings.
-$92M in FY2025.
Declined from -$84M to -$92M over the past 3 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Korro Bio, Inc.'s operating income has declined for 5 consecutive years.
- In FY2025, operating income decreased 8.7% year-over-year.
- Peak operating income was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$91.9M | -8.7% |
| FY2024 | -$84.5M | -0.6% |
| FY2022 | -$84.0M | -205.0% |
| FY2021 | -$27.6M | -33.3% |
| FY2020 | -$20.7M | -26.8% |
| FY2019 | -$16.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026